-
Cipla receives USFDA approval for Generic Abraxane
11 Apr 2025 05:07 GMT
… of Bristol Myers Squibb’s Abraxane® in the United States.
Cipla … is a therapeutic equivalent to Abraxane®, a widely used chemotherapy drug … or metastatic non-small cell lung cancer (NSCLC), and metastatic adenocarcinoma of …
-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… worse and survival. In contrast, Abraxane was more effective than conventional … metastatic adenocarcinoma of the pancreas, Abraxane was shown to improve overall … non-small cell lung cancer, 33% of patients receiving Abraxane and carboplatin responded …
-
Does US approval for key cancer drug make Cipla shares an attractive buy amid tariff concerns?
17 Apr 2025 08:24 GMT
… Earlier-than-expected approval for Abraxane is positive, but tariffs … recent approval of generic Abraxane could give Cipla a … metastatic non-small cell lung cancer, and metastatic adenocarcinoma of … US revenue from generic Abraxane for FY26. More importantly …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
-
Cipla’s generic drug for cancer gets U.S. FDA nod
11 Apr 2025 19:40 GMT
… Myers Squibb’s cancer drug Abraxane has received final approval from … of Bristol Myers Squibb’s Abraxane for Injectable Suspension 100 mg … or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the …
-
Cipla cancer generic receives FDA final nod
11 Apr 2025 15:13 GMT
… of Bristol Myers Squibb’s Abraxane, indicated for the treatment of … -small cell lung cancer (‘NSCLC’) and metastatic adenocarcinoma of the pancreas.
Abraxane is …
-
Cipla Limited receives USFDA final approval for ANDA Protein-bound Paclitaxel
11 Apr 2025 12:46 GMT
… Bristol Myers Squibb's Abraxane® for Injectable Suspension 100 mg … or metastatic non-small cell lung cancer ('NSCLC') and metastatic …
-
Latest News | Cipla Gets USFDA Nod for Generic Cancer Drug
11 Apr 2025 07:10 GMT
… Bristol Myers Squibb's Abraxane for injectable suspension 100 mg … or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
About
© 1995-2025